What if the bed we sleep in could measurably reduce stress, eliminate body pain and make people sharper the next morning, proven by independent scientists and not just marketing claims?
That's not a promise. It's a finding from a peer-reviewed clinical study published in April 2026 by the beScored Institute, in collaboration with the European Sleep Center Paris and the results are hard to ignore.
The world is facing a sleep crisis and most people are not fully aware of its impact.
Sleep deprivation has become so normalized that many assume feeling tired, tense and mentally foggy is simply part of modern life. It is not, and it should not be.
Approximately 10% of adults meet the clinical criteria for insomnia disorder, while a further 20% experience regular insomnia symptoms. Poor sleep is associated with elevated cortisol levels, impaired memory and concentration, lower pain tolerance, and a significantly higher risk of anxiety and depression. Overtime, chronic sleep disruption does not only make people feel tired. It reshapes their physiology.
The problem is compounded by the fact that most sleep solutions demand effort, such as therapy, apps, supplements or meditation routines. They require motivation and discipline at the exact moment of the day when those are hardest to find.
This is the gap that smart bed technology was designed to fill. It is also why the science behind it matters so much. For this reason, Ergomotion® set out to validate its approach through credible testing conducted by independent institutions capable of rigorously evaluating the results.
What the Study Did and Why It's Credible
The beScored Institute study titled “Effects of Ergomotion® Bed Use on Mental and Physical Well-being” was designed to answer a deceptively simple question. Does sleeping in an Ergomotion® smart bed make a measurable difference to your health?
To answer this rigorously, researchers used a randomised crossover design, the same format used in pharmaceutical clinical trials.
- 12 adult participants (9 women, 3 men,average age 49) were recruited specifically because they suffered from insomnia (ISI score > 14) and elevated stress (PSS score > 13). These weren't healthy volunteers who already slept well; they were people who genuinely struggled.
- Each participant spent 14 nights on the Ergomotion® bed and 14 nights on their own personal bed, in their own home, in random order, separated by a two-week washout period.
- Before and after each phase, participant underwent a comprehensive battery of tests measuring sleep quality, stress biomarkers, heart rate variability, cognitive performance, mental fatigue, body pain, and perceived well-being.
The crossover design is powerful because each person acts as their own control, eliminating the individual variation that can muddy results in conventional group studies.
The research team included scientists from the beScored Institute, Université de Bourgogne, Université Côte d'Azur, the European Sleep Center Paris, Nantes Université, and the University of Technology Sydney. Eight researchers across six institutions, bringing expertise in exercise physiology, sleep medicine, neuroscience, and biostatistics.
The Results: Six Outcomes That Speak for Themselves
1. Body Pain: Complete Elimination
This is the most striking finding in the entire study.
At the end of the Ergomotion® phase, every single participant reported zero pain. Not reduced pain. Zero.
Pain scores sat between 14 and 15 at baseline and remained stable throughout the control condition. After 14 nights with the Ergomotion® bed, they dropped to zero. A statistically significant result (p = 0.009).
For context, the participants in this study reported pain across multiple body areas including muscular, articular, and tension-related discomfort. The mechanisms behind the improvement likely involve better spinal alignment, reduced pressure point loading through the adjustable positioning system, and the parasympathetic nervous system reset that quality sleep enables.
For anyone living withchronic tension, back pain, or musculoskeletal discomfort, this matters.
2. Mental Fatigue: −30%
The study measured mental fatigue both subjectively (through a validated visual analog scale, M-VAS) and objectively (through saccadic eye movement tracking, a scientifically established proxy for central fatigue).
Perceived mental fatigue fell 30% in the Ergomotion® group. A statistically significant interaction (p =0.005). By contrast, the same participants' fatigue actually increased by 13.6% during the control phase.
That divergence is meaningful. It suggests the Ergomotion® bed isn't just helping people feel slightly better rested, but it's producing a qualitatively different recovery state.
3. Cortisol: −26.5%
Cortisol is your body's primary stress hormone. It follows a natural daily rhythm: high in the morning to wake you, declining through the day, and low at night. When this rhythm is disrupted, as it frequently is in people with insomnia and chronic stress. The downstream effects cascade across mood, immune function, metabolism, and cognitive performance.
After 14 nights on the Ergomotion® bed, salivary cortisol dropped by 26.5% (p = 0.017 in post-hoc analysis). Levels remained flat in the control condition.
This isn't a self-reported feeling. Cortisol was measured by a certified biological laboratory using salivary samples collected under controlled conditions. The 26.5% reduction represents a genuine physiological shift. The kind that takes weeks of meditation practice, pharmaceutical intervention, or significant lifestyle change to achieve through conventional means.
4. Insomnia Severity: −19.2%
Participants entered the study with moderate insomnia scores. After the Ergomotion® phase, their Insomnia Severity Index scores fell by 19.2%, moving them from the moderate insomnia category toward the sub threshold range. In clinical terms, crossing that threshold is significant. It's the point at which insomnia stops significantly impairing daily function.
The control condition also showed some improvement (−7.9%), which is expected when any study gives people structured attention to their sleep. But the Ergomotion® improvement was more than twice as large.
5. Heart Rate Variability:+9.6% SDNN
Heart Rate Variability (HRV)is a measure of the variation in time between heartbeats. Counter intuitively, more variation is better. It indicates that your autonomic nervous system is flexible, responsive, and in good recovery shape. Low HRV is associated with stress, over training, illness, and poor sleep.
SDNN — the standard deviation of RR intervals, a key HRV metric improved by 9.6% with the Ergomotion® bed. RMSSD, another HRV index reflecting parasympathetic tone, improved by 3.2%.
These numbers reflect a nervous system that is recovering more effectively overnight.
6. Well-being and Bedtime Behavior
Perceived well-being on the Ergomotion® phase improved by 10.5% compared to pre-condition baseline. But one of the most quietly revealing findings was behavioral: participants went to bed significantly earlier during the Ergomotion® phase (p = 0.038).
No one told them to. They just wanted to.
This suggests something beyond measured outcomes. The Ergomotion® bed changed how people felt about going to bed. Sleep became something they moved toward rather than away from. In clinical terms, this matters enormously: bedtime avoidance is a core feature of insomnia that perpetuates the condition.
How the Ergomotion® Bed Actually Works
The results above didn't come from passive lying on a mattress. The Ergomotion® smart bed integrates several active features that work together across the night.
- Adjustable positioning and zero-gravity mode allow users to find positions that reduce spinal compression, improve circulation, and lower pressure point loading. Particularly relevant for back pain and acid reflux.
- Micro-vibrations provide low-frequency mechanical stimulation that promotes muscle relaxation and has been shown in other research to support autonomic nervous system down regulation.
- A 7-minute pre-sleep relaxation routine, delivered through a guided voice program with coordinated bed movements and micro-vibrations, primes the nervous system for sleep onset. In the study, all participants used an identical standardised routine, making the results directly attributable to the technology rather than individual habits.
- Integrated sleep sensors continuously monitor heart rate, respiratory rate, movement, and sleep stages throughout the night, providing the same quality of data used in the research for every user, every night.
The Oura Ring Comparison: What It Means for You
One of the most technically significant parts of the study was a direct comparison between the Ergomotion® bed's built-in sensors and one of the most popular and well-validated consumer sleep trackers on the market.
The results were reassuring:
- Heart rate ICC = 0.98(excellent agreement)
These figures mean that the data of Ergomotion® bed provides about sleep isn't an approximation, but reliable information, comparable to a dedicated wearable device that most sleep-interested consumers already trust.
Who This Research Was Built For
The study population is worth emphasising these were adults aged 35–65 with confirmed insomnia and elevated stress. Not athletes. Not people optimizing already-good sleep. People who were struggling. The kind of people who lie awake worrying, wake up exhausted, and carry chronic tension in their bodies through the day.
The fact that meaningful improvements were observed in just 14 nights, in a home environment, without any additional intervention, is what makes this research commercially and clinically significant.
It also means the results speak directly to the majority of working adults.
Sleep Better. Think Clearer. Hurt Less.
The story of this research is ultimately simple: the environment where people sleep shapes who they are when they wake up.
For decades, the bed was treated as passive furniture. Something to put a mattress on. The Ergomotion® smart bed reframes it as an active sleep system, one that works while people rest, calibrating their position, stimulating recovery, and tracking the quality of the night so users can understand and improve their health over time.
The science, conducted independently by researchers with no commercial stake in the outcome, confirms that this reframing is justified.
A 26.5% reduction in cortisol. Zero pain. Thirty percent less mental fatigue. Better HRV. Earlier,more willing sleep.
These aren't aspirational claims. They're data.
Ready to Experience the Difference?
The Ergomotion® smart bed is available through numerous partners worldwide in 59 countries. To explore models, compare features, or speak with one of our Sales Manager, reach out to us and make part of the revolution of sleep industry.
Want to read the full study? The complete scientific reports, including methodology, statistical analysis,and device comparison data — click here: The Science of Better Sleep, Proven
Elevate your business with Ergomotion®.
.png)
